Last A$0.04 AUD
Change Today +0.008 / 24.24%
Volume 828.4K
RHT On Other Exchanges
As of 9:10 PM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

resonance health ltd (RHT) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/13/14 - A$0.11
52 Week Low
08/28/13 - A$0.01
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for RESONANCE HEALTH LTD (RHT)

Related News

No related news articles were found.

resonance health ltd (RHT) Related Businessweek News

No Related Businessweek News Found

resonance health ltd (RHT) Details

Resonance Health Limited, a healthcare company, is engaged in the development and commercialization of magnetic resonance imaging (MRI) related technology for the diagnosis and management of human disease. The company’s principal product is FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver. It is also developing imaging tools for the quantification of liver fat and liver fibrosis to address clinical need for patients with fatty liver disease and viral hepatitis. In addition, the company provides various core lab services to the pharmaceutical industry. It operates in Australia, the United Kingdom, Germany, and the United States, as well as provides its products and services through distributors in the Middle East and Turkey. Resonance Health Limited is headquartered in Claremont, Australia.

resonance health ltd (RHT) Top Compensated Officers

Managing Director and Executive Director
Total Annual Compensation: A$250.0K
Chief Scientific Officer and Executive Direct...
Total Annual Compensation: A$94.5K
Compensation as of Fiscal Year 2013.

resonance health ltd (RHT) Key Developments

Resonance Health Ltd., Annual General Meeting, Nov 14, 2013

Resonance Health Ltd., Annual General Meeting, Nov 14, 2013., at 10:00 W. Australia Standard Time. Location: 278 Stirling Highway. Agenda: To consider adoption of remuneration report; to consider re-election of Dr. Martin Blake; and to consider re-election of Dr. Jason Loveridge.

Resonance Health Wins Contract for Ferriscan Services

Resonance Health Ltd. has been awarded a new two-year contract by a large international pharmaceutical company to provide Ferriscan services to evaluate a therapy to treat patients with chronic transfusional iron overload. Resonance Health will be working with approximately 25 MRI facilities across a number of countries. The radiology facilities will be trained by Resonance Heath in the Ferriscan imaging requirements and will perform the patient MRI scanning during the clinical trial.

Resonance Health Ltd. to Report First Half, 2013 Results on Feb 28, 2013

Resonance Health Ltd. announced that they will report first half, 2013 results on Feb 28, 2013


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RHT:AU A$0.04 AUD +0.008

RHT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RHT.
View Industry Companies

Industry Analysis


Industry Average

Valuation RHT Industry Range
Price/Earnings 100.0x
Price/Sales 6.6x
Price/Book 6.0x
Price/Cash Flow 69.6x
TEV/Sales 6.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESONANCE HEALTH LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at